Sharon M. Castellino

Director, Pediatric Leukemia/Lymphoma @ATL peds; Professor@EmoryMed; Lymphoma; Survivorship/Outcomes; Reducing Disparities; #WomenInMedicine. Views are my own.

[Children’s Oncology Group @COGorg]

May is National Cancer Research Month. This year, the AACR is highlighting the theme “United by Cancer Research.” Throughout May, COG will share stories that show how our global network unites experts and institutions to drive breakthroughs in pediatric oncology research.

[Children’s Oncology Group @COGorg]

In 2024, a trial focused on improving treatment for the most common pediatric cancer was closed 2 years early thanks to collaboration across the COG network. That speed matters to kids with B-cell Acute Lymphoblastic Leukemia, a rapidly progressing cancer.
https://t.co/BmDkJxvFFI

[Children’s Oncology Group @COGorg]

Since 1998, @hopeonwheels has supported the infrastructure behind COG’s life-changing research. From biospecimen storage to clinical trial support, their investment helps advance new treatments and better outcomes for pediatric cancer patients.
https://t.co/ZUvr84lZeu

[Aflac Cancer and Blood Disorders Center @ATLPedsHemOnc]

Our own Dr. @SharonCastelli2 and Dr. Kara Kelly of @RoswellPark published teen cohort results from a landmark phase 3 clinical trial confirming the benefit of a nivolumab combo for advanced Hodgkin lymphoma in @JCO_ASCO. Learn more: https://t.co/pK0qmv9U8J.

[BeOne Medicines @BeOneMedicines]

What happens when patient advocates, healthcare leaders, and AI innovators unite? Magic, and a healthy discussion that drives real innovation.

At our Patient Advocacy AI Innovation Lab at #ASH2025, 60% of attendees already use AI tools in their work, yet 54% worry about reliability in cancer care. This tension is where breakthroughs happen.

Three key insights emerged:

1) Advocates are essential guides. As Meghan Gutierrez from @lymphoma said: "Meet patients where they are—even if they arrive before we do." Those on the front lines know what will work.

2) Trust must be earned. Verification, transparency, and human oversight aren't optional—they're fundamental.

3) Cross-industry innovation sparks breakthrough thinking. Case studies from Disney, Expedia, and Lemonade helped us reimagine patient onboarding, treatment planning, and friction reduction—while keeping human connection at the center.

This is just the beginning. Thank you to our speakers and every advocate who challenged us to think differently.

Together, we're ensuring AI serves humanity in the fight against blood cancer.

[Aflac Cancer and Blood Disorders Center @ATLPedsHemOnc]

Interested in learning about the latest topics in pediatric hematology? Our team will be attending and presenting on a variety of topics at @ASH_hematology's 67th Annual Meeting and Exposition, from December 6-9 in Orlando. Learn more: https://t.co/BlwILGIETT. #ASH25

[Xu Ji, PhD, MSPH @XuJi2022]

Our @JNCI_Now study shows that receiving survivorship care plan, embedded in a comprehensive survivorship program, is associated with improved survival among childhood cancer survivors. @SharonCastelli2 @DrEffinger @JordanGMarchak @WinshipAtEmory @ATLPedsHemOnc @EmoryPediatrics

[Blood Cancer United Advocacy @bcutd_advocacy]

At @BloodCancerUtd, we're all about the Accelerating Kids' Access to Care Act, so kids with cancer can be about everything else. Watch to learn more about the bill and how it can help kids with cancer ⬇️

[Children’s Oncology Group @COGorg]

The #COGF Newsletter - Summer 2025 is here! This edition covers liquid biopsies, coordinating clinical trials, B+ Foundation philanthropic support, & an interview w/ AYA Chair, Mike Roth. https://t.co/4AnP0wNLGk

[Toby Eyre @tobyeyre82]

Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826 | Journal of Clinical Oncology https://t.co/wopz4ldUI6

[Blood Cancer United Advocacy @bcutd_advocacy]

Kids with cancer deserve a chance to thrive. But in December, Congress missed a key opportunity to extend programs that incentivize drug companies to find them cures. Learn more about the Give Kids a Chance Act, and how it can help children with cancer ⬇️
https://t.co/BzCmTV1nqS

[Sharon M. Castellino @SharonCastelli2]

#AACR25
Honored to co-chair (with Mimi Bondopadhayay) great science - mini symposium on #Pediatric Advances_Bench to Bedside.

[Blood Cancer United Advocacy @bcutd_advocacy]

Check out the latest findings from @NavigatorSurvey, which found that an overwhelming number of Americans want the healthcare tax credit extended and would back members of Congress who do so ⬇️
https://t.co/QzPi98QR0i #NoHealthcareCuts

[Children's Cancer Cause @childrenscause]

Members of Congress are now back in their home districts for a 2-week spring recess. Check the websites of your Senators and Rep to find out if there are events happening near you that might give you the chance to speak up about #ChildhoodCancer issues like NCI funding.

[Children’s Oncology Group @COGorg]

The #COGF Newsletter - Spring 2025 is here! This edition covers the road from idea to clinical trial, a foundations philanthropic support for kidney cancer research, an interview w/ Renal Chair, Nicholas Cost, & a letter from our Group Chair, Doug Hawkins. https://t.co/4AnP0wNLGk

[Sharon M. Castellino @SharonCastelli2]

@mcuban Thank you Mark Cuban. Our pediatric oncology social workers turn to #costplus often. …And yes research in the US has led massive advances for children with cancer, infectious diseases, and many rare diseases.

[Blood Cancer United Advocacy @bcutd_advocacy]

Some in Congress are rushing to cut $880B from #Medicaid. These cuts will terminate healthcare for 10M people, including blood cancer patients. Without coverage, many will not be able to afford care.

Tell your Senator to oppose Medicaid cuts ⬇️
https://t.co/SzowXyyheI

[ASH @ASH_hematology]

ASH and 90+ Organizations Call for HHS to Immediately Restore CDC’s Division of Blood Disorders. Without it, patients with blood diseases face preventable risks.

ASH is calling for its restoration.

🔗 https://t.co/fgdAmtttDb

#Fight4Hematology

[Sharon M. Castellino @SharonCastelli2]

Working to support #AYA patients from diagnosis through survivorship
@ATLPedsHemOnc with treatment, supportive care and policy advocacy

[Aflac Cancer and Blood Disorders Center @ATLPedsHemOnc]

In honor of #AYACancerAwarenessWeek, we want to recognize our AYA patients and the dedicated staff who are working to make tremendous strides to bridge the gap from patient diagnosis to survivorship.

[Sharon M. Castellino @SharonCastelli2]

@lab_rezvani @EladSharonMD @NatureMedicine Congratulations Katy. Look forward to seeing this work advance to trials inclusive of adolescents.